Dr. Wimms brings two decades of sleep medicine industry and research expertise to her advisory role at Incannex. Dr. Wimms holds a Doctor of Philosophy (Ph.D.) in Medicine, and Master of Medicine ...
As per Future Market Insights, PSG devices are expected to be the most preferred sleep apnea diagnostic systems during the ...
Obstructive sleep apnea ... Daytime drowsiness puts people with sleep apnea at risk for motor vehicle crashes and industrial accidents. Treatment can help to completely relieve daytime drowsiness.
Signifier Medical secures EU MDR certification for eXciteOSA®, ensuring safety, efficacy, and broader access to its ...
In the wake of the U.S. Food and Drug Administration’s approval of Zepbound to treat moderate to severe obstructive sleep ...
FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
ResMed stock is down today, even though the maker of CPAPs and other respiratory treatment devices had Street-beating Q2 ...
For pediatric insomnia, Dr Umakanth Katwa and Dr Rafael Pelayo call for a blend of clinical expertise, behavioral therapy, and empathy.
therapy can improve the lives of people with obstructive sleep apnea, but nearly half of adults with CPAP machines fail to adhere to a regular regimen of ... Phosphorylation and Dephosphorylation ...
Q2 2025 Earnings Call Transcript January 30, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32. Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback